Patient Package Inserts: The Proper Prescription?

March 1995

Issue: 50 Food and Drug Law Journal95-124 (1995)

The late 1960s witnessed the emergence of the patient package insert (PPI). This article traces the history of PPIs, in light of recent calls to expand their usage and to be included in all prescription drugs. A review of the literature reveals that PPIs do comport with rationales given for their use, namely informed consent and patient education. The article concludes, however, that these rationales for PPIs strain rationales used to justify the prescription status of some drugs.


FDLI's policy regarding the Food and Drug Law Journal online is: Only the Table of Contents and article abstracts for each issue will be posted to our website. Those visitors wishing to obtain a full text version of a particular article, or a copy of an entire issue, may contact FDLI’s Customer Service Department by e-mail at Your purchase will be processed quickly, and at reasonable rates.

Any questions or concerns regarding this policy should be directed to Michael Levin-Epstein,
FDLI's Editor-in-Chief.